Mace, Jackson W. https://orcid.org/0000-0001-9555-4759
Gadani, Sachin P.
Smith, Matthew D. https://orcid.org/0000-0001-6614-569X
Galleguillos, Danny https://orcid.org/0000-0001-6987-9322
Kang, Bong Gu
Roy, Milton
Liu, Meilian
Summers, Benjamin
Garton, Thomas https://orcid.org/0000-0001-9352-8530
Gharagozloo, Marjan https://orcid.org/0000-0002-2166-4012
Gill, Alexander J.
Pardo, Carlos A. https://orcid.org/0000-0002-4128-5335
Sotirchos, Elias S. https://orcid.org/0000-0002-8812-1637
Dawson, Valina L. https://orcid.org/0000-0002-2915-3970
Dawson, Ted M.
Calabresi, Peter A. https://orcid.org/0000-0002-7776-6472
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS041435)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (F31NS132520)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS065725)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS065725)
U.S. Department of Defense (W81XWH2210819)
National Multiple Sclerosis Society (FAN-2106-37832)
National Multiple Sclerosis Society (TA-2407-43578)
National Multiple Sclerosis Society (TA-2104-37423)
National Multiple Sclerosis Society (FAN-2007-36944)
Article History
Received: 23 November 2024
Accepted: 6 January 2026
First Online: 17 February 2026
Change Date: 10 March 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41593-026-02246-8
Competing interests
: T.M.D. and V.L.D. have filed patents on the use of MIF nuclease inhibitors to treat neurologic disorders. All other authors declare no competing interests.